Speaker Profile
Biography
Elad Ziv is a physician-scientist whose research focuses on germline genetic susceptibility to cancer and treatment outcomes. His group focuses on genetics of breast cancer in Latinas and on genetics of immunotherapy. He and his colleagues have often leveraged concepts from population genetics to help guide their studies of cancer. He completed his undergraduate degree at Yale University and received his MD from UCSF where he also completed residency training in internal medicine and fellowship training in epidemiology and clinical research. He is an elected member of the American Society for Clinical Investigation.
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Ed Kim, City of Hope
PMWC Award Ceremony
• Mark Daly, Broad Institute / FinnGen
• Gordon Sanghera, Oxford Nanopore Technologies
The Data Factory: Integrating Millions of Genomes for Variant Interpretation
• Chair: Stephen Montgomery, Stanford University
• Carlos Bustamante, University of Oklahoma
• Mark Daly, Broad Institute
• Manuel Rivas, Stanford University
• Mark McCarthy, Genentech
• Nilah Ioannidis, UC Berkeley / UCSC
Keynote: Biobanks and the Road Ahead in Human Genetics
• Mark Daly, Broad Institute
Beyond the Read: Long-Read Sequencing in Clinical Variant Pipeline
• Chair: Kathleen Barnes, Galatea Bio
• Gordon Sanghera, Oxford Nanopore Technologies
• Hanlee Ji, Stanford
• Barrett Bready, Nabsys
DNA to Drug, Label & Coverage
• Chair: Razelle Kurzrock, Medical College of Wisconsin
• Edward Kim, City of Hope
• Slavé Petrovski, AstraZeneca
• Wei Zhou, Broad Institute
PMWC Award Ceremony
• Scott Gottlieb, New Enterprise Associates
Fireside Chat
• Lauren Silvis, Tempus
• Scott Gottlieb, New Enterprise Associates
25+ Years of the Human Genome: From Bench to Bedside to Beyond
• Chair: Ralph Snyderman, Duke University
• Craig Venter, J. Craig Venter Institute
• Brook Byers, KPCB
• Lee Hood, Phenome Health




